Circulating Tumor Cells, From Biotech Innovation to Clinical Utility Part B
Series: International Review of Cell and Molecular Biology; 392;
- Publisher's listprice EUR 171.00
-
72 538 Ft (69 084 Ft + 5% VAT)
The price is estimated because at the time of ordering we do not know what conversion rates will apply to HUF / product currency when the book arrives. In case HUF is weaker, the price increases slightly, in case HUF is stronger, the price goes lower slightly.
- Discount 10% (cc. 7 254 Ft off)
- Discounted price 65 284 Ft (62 176 Ft + 5% VAT)
72 538 Ft
Availability
Not yet published.
Why don't you give exact delivery time?
Delivery time is estimated on our previous experiences. We give estimations only, because we order from outside Hungary, and the delivery time mainly depends on how quickly the publisher supplies the book. Faster or slower deliveries both happen, but we do our best to supply as quickly as possible.
Product details:
- Publisher Academic Press
- Date of Publication 1 May 2025
- ISBN 9780443136559
- Binding Hardback
- No. of pages208 pages
- Size 229x152 mm
- Weight 450 g
- Language English 700
Categories
Long description:
Circulating Tumor Cells, From Biotech Innovation to Clinical Utility Part B, Volume 392 in the International Review of Cell and Molecular Biology series, highlights new advances in the field, with this new volume presenting interesting chapters on a variety of timely topics, including Circulating Tumor Cells in Lung Cancer: integrating stemness and heterogeneity to improve clinical utility, Multi-omic Features and Clustering Phenotypes of Circulating Tumor Cells Associated with Metastasis and Clinical Outcomes, CTCs in CRC: updates, Proteomics and post-translational modification analysis in CTCs, Latest advances of CTC studies in prostate cancer, and Epigenetics and CTCs: new biomarkers and impact on tumor biology.
- Provides the latest information on cancer research
- Offers outstanding and original reviews on a range of cancer research topics
- Serves as an indispensable reference for researchers and students alike
Table of Contents:
1. Circulating Tumor Cells in Lung Cancer: integrating stemness and heterogeneity to improve clinical utility
Giulia Bertolini and Giuseppe Lo Russo
2. Multi-omic Features and Clustering Phenotypes of Circulating Tumor Cells Associated with Metastasis and Clinical Outcomes
Lamiaa El-Shennawy
3. CTCs in CRC: updates
Pashtoon Kasi
4. Proteomics and post-translational modification analysis in CTCs
Huiping Liu
5. Latest advances of CTC studies in prostate cancer
Paraskevi Giannakakou
6. Epigenetics and CTCs: new biomarkers and impact on tumor biology
EVRYKLEIA LIANIDOU and Aliki Ntzifa
